Furthermore, in the MB49 orthotopic tumor model, we found that either inhibition of AhR, IDO1 or SLC7A5 could achieve synergistic effect with cisplatin (Supplementary Fig. 7N). This evidence concerns the gene SLC7A5 and neoplasm.